Claire Gallagher

Ms. Claire Gallagher

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2023 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
CGClaire Gallagher
Claire Gallagher
JPJane Pirkis
Jane Pirkis
KLKatrina A Lambert
Katrina A Lambert
JPJennifer L. Perret
Jennifer L. Perret
GAGulshan B. Ali
Gulshan B. Ali
BEBircan Erbas
Bircan Erbas
Background/Objective: Obesity is a risk factor for multimorbidity, including depression and possibly anxiety. However, it is currently unclear how patterns of change in BMI over the life course differentially influence the magnitude in risk of depression and anxiety in mid-adulthood. We aimed to examine associations between BMI trajectories from childhood to adulthood and the risk of depression and anxiety in middle age. Methods: In the Tasmanian Longitudinal Health Study (n = 2416), five distinct BMI trajectories were previously defined from age 5 to 45 years using group-based modelling. At age 53, current depression and anxiety were assessed using the Patient Health Questionnaire and the Generalized Anxiety Disorder scale, respectively. Logistic regression models adjusted for potential confounders estimated associations between BMI trajectories and these outcomes. Results: Those belonging to the child average-increasing (OR = 2.24; 95%CI: 1.24, 4.06) and persistently high (OR = 2.64; 1.26, 5.52) trajectories were more likely to have depression in middle age, compared to the persistently average trajectory. However, the odds of experiencing greater severity of depressive symptoms was highest in the child average-increasing group (OR = 2.36; 1.59, 3.49). Despite finding no evidence of association between BMI trajectories and current anxiety, we observed less severe symptoms in the child high-decreasing trajectory (OR = 0.68; 0.51, 0.91). Conclusion: We found an increased risk of depression in middle age among individuals with a persistently high BMI from childhood to mid-adulthood and individuals with an average BMI in childhood which then increased consistently throughout adulthood. Encouragingly, resolving childhood adiposity by adulthood was associated with lesser anxiety symptoms. Taken together, these findings highlight the need to target mental health screening and treatment towards high-risk BMI trajectory groups and the importance of early interventions to prevent and resolve excess weight.

22 August 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
YBYibeltal Bekele
Yibeltal Bekele
CGClaire Gallagher
Claire Gallagher
MBMehak Batra
Mehak Batra
DVDon Vicendese
Don Vicendese
MBMelissa Buultjens
Melissa Buultjens
BEBircan Erbas
Bircan Erbas
Background: Despite recent evidence demonstrating iron and folate supplementation reduces the risk of low birth weight and preterm births, synthesis of the evidence is not sufficient to understand their impacts in Africa. Method: MEDLINE, PsycINFO, Embase, Scopus, CHINAL, Web of Science, Cochrane databases, and Google Scholar were searched for the published and grey literature. Either iron-only, folate-only, or iron–folic acid (IFA) oral supplementation during pregnancy was the primary exposure/intervention. The focus of this review was low birth weight and preterm births in the African region. Qualitative synthesis, meta-analysis, and subgroup analysis were employed. Results: In the qualitative synthesis (n = 4), IFA supplementation showed a positive impact on reducing preterm birth. Additionally, the meta-analysis showed that IFA and iron-only supplementation reduced the odds of low birth weight by 63% (OR 0.37; 95% CI: 0.29, 0.48) and 68% (OR 0.32; 95% CI: 0.21 to 0.50), respectively. Conclusion: Both iron-only and IFA supplementation are effective in reducing the risk of low birth weight in Africa. There is also promising evidence suggesting a potential reduction in preterm births. Consequently, further research is needed, particularly targeting high-risk groups such as women residing in rural areas with limited support and low levels of literacy.

YBYibeltal Bekele
Yibeltal Bekele
CGClaire Gallagher
Claire Gallagher
DVDon Vicendese
Don Vicendese
MBMelissa Buultjens
Melissa Buultjens
MBMehak Batra
Mehak Batra
BEBircan Erbas
Bircan Erbas
Background: Iron and folate deficiency are prevalent in pregnant women in Africa. However, limited research exists on the differential effect of oral iron-only, folate-only, or Iron Folic Acid (IFA) supplementation on adverse pregnancy and infant outcomes. This systematic review addresses this gap, focusing on studies conducted in Africa with limited healthcare access. Understanding these differential effects could lead to more targeted and potentially cost-effective interventions to improve maternal and child health in these settings. Methods: A systematic review was conducted following PRISMA guidelines. The primary exposures were oral iron-only, folate-only, or IFA oral supplementation during pregnancy, while the outcomes were adverse pregnancy and infant outcomes. A qualitative synthesis guided by methods without meta-analysis was performed. Results: Our qualitative synthesis analysed 10 articles reporting adverse pregnancy (adverse birth outcomes, stillbirths, and perinatal mortality) and infant outcomes (neonatal mortality). Consistently, iron-only supplementation demonstrated a reduction in perinatal death. However, evidence is insufficient to assess the relationship between iron-only and IFA supplementation with adverse birth outcomes, stillbirths, and neonatal mortality. Conclusion: Findings suggested that iron-only supplementation during pregnancy may reduce perinatal mortality in African women. However, evidence remains limited regarding the effectiveness of both iron-only and IFA supplementation in reducing stillbirths, and neonatal mortality. Moreover, additional primary studies are necessary to comprehend the effects of iron-only, folate-only, and IFA supplementation on pregnancy outcomes and infant health in the African region, considering rurality and income level as effect modifiers.

1 January 2026 in Journal of Obesity
Verified
Journal Article
Open access
JSJules J. Sing
Jules J. Sing
CGClaire Gallagher
Claire Gallagher
XDXin Dai
Xin Dai
NINur Sabrina Idrose
Nur Sabrina Idrose
CBCatherine Bennett
Catherine Bennett
CLCaroline Lodge
Caroline Lodge
Background/Objective: Antibiotic exposure by 2 years is linked to increased childhood overweight/obesity risk, mainly in cross‐sectional studies. Few longitudinal studies exist in high‐risk populations, and none examined BMI trajectories up to 18 years. Our study is the first to investigate the association between early antibiotic exposure and BMI trajectories in a high allergy‐risk cohort. Methods: We analysed data from 428 participants in the Melbourne Atopy Cohort Study from birth to 18 years. Antibiotic use < 2 years was categorized as “ever versus never” and according to seven antibiotic classes. Number of courses (7 days) and the spectrum of antibiotics (broad versus narrow) were defined for each antibiotic class. Logistic regression models estimated associations between antibiotic use (any/specific), courses (0, 1, 2, and ≥ 3), and previously defined BMI trajectories from 4 weeks to 18 years: very low catch‐up, low average, stable average (reference), average increasing to very high (AIVH), and persistently high (PH). Results: We found consistent evidence of a relationship between antibiotic exposure by 2 years and increased risk of belonging to AIVH and PH trajectories, with magnitudes of effect differing by antibiotic spectrum and frequency. Notably, exposure to ≥ 3 courses of broad‐spectrum antibiotic was associated with the AIVH (aOR = 3.36 [95% CI: 1.03, 10.87]) and PH trajectories (aOR = 3.29 [95% CI: 1.03, 10.53]). Conclusion: These findings may have important clinical implications, but further large‐scale studies are required.